BioDelivery Sciences (NSDQ:BDSI) said last week that its president & CEO, Mark Sirgo, plans to retire at the end of this year.
Sirgo has held the corner office at the Raleigh, N.C.-based company since 2005. He will stay on as vice chairman of the board and will help determine his successor, BioDelivery Sciences reported.
Get the full story at our sister site, Drug Delivery Business News.
The post BioDelivery Sciences president, CEO Sirgo to retire | Personnel Moves – Aug 29, 2017 appeared first on MassDevice.